![](https://investorshub.advfn.com/uicon/726995.png?cb=1699372106)
Sunday, February 19, 2023 2:18:55 PM
"Really? I notice you created your own "title" for this article"
Not true ....that was the title for the article on the NY Times website
"February 16, 2023 • 11:57 a.m.
Why U.S. odds are stacked against a promising new COVID drug
The New York Times, February 8, 2023"
https://globalnews.ca/news/9470563/covid-antiviral-peginterferon-lambda-study/
"The new therapy was conducted in Toronto and used in more than 1,900 outpatients at high risk of developing complications from COVID-19, the statement from NEJM said."
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM